@TheoFleury14 Wow didn’t know you have crohns, I’v

@TheoFleury14 Wow didn’t know you have crohns, I’ve had it since 1980 . Very difficult to deal with through out my life

@TheoFleury14 Send money to me too, I have Crohns

@TheoFleury14 Send money to me too, I have Crohns
Take high doses of vitamin D!

I am thrilled to share that I have started my new role with @LPPNHS

Very much looking forward to joining the fanta… https://t.co/QPFWsTiZDe

Daily Updates on Generic Entry, Litigation, Biosimilars, and more with the DrugPatentWatch Daily Briefing. Sign up… https://t.co/8AYnj2jqL9

ICYMI: Dr Ivo Abraham, chief scientist of Matrix45 and a professor at the @uarizona details how #biosimilar guideli… https://t.co/fi3Pxo2prb

Biosimilars and Follow-On Biologics Market predicted to increase by 31.14% to 2033 > Download this new #Pharma repo… https://t.co/v4yYlMLmy1

Three articles originally published on Rothwell Figg’s emerging companies and biosimilars blogs are among @JDSupra’… https://t.co/pHYNZBEYPv

THIS👉”Many of the excluded products may be generics or biosimilars with lower list prices, which the PBMs push asid… https://t.co/HKCtfWNDaF

With 2023 poised to be the year of the #Humira biosimilar wave, @cardinalhealth has issued a new report on market e… https://t.co/XhmTSIHnHl